Former FDA Reviewer Shares Agency Insight On New Clinical Technology

Comments
Former FDA Reviewer Shares Agency Insight On New Clinical Technology

Ruthie Davi, former FDA Deputy Director and Statistician, and Scott Fisher, Medidata‚Äôs Principal Platform Strategist, discuss how data and technology are advancing drug development and changing the life sciences landscape in a recent webcast.

The webcast links market trends around new uses in clinical trial technology that regulatory bodies are encouraging, but that study stakeholders find challenging to implement. Watch the webcast now to learn more about trends such as:

  • Adaptive Trial Design to improve study plan

  • Risk Based Monitoring to improve site support

  • New endpoints to improve patient engagement

  • Personalized Medicine to improve study conduct

About Author

Geeks Talk Clinical